Chiara Cavalloni

1.6k total citations
15 papers, 524 citations indexed

About

Chiara Cavalloni is a scholar working on Genetics, Molecular Biology and Rheumatology. According to data from OpenAlex, Chiara Cavalloni has authored 15 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in Chiara Cavalloni's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (8 papers) and Kruppel-like factors research (6 papers). Chiara Cavalloni is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (8 papers) and Kruppel-like factors research (6 papers). Chiara Cavalloni collaborates with scholars based in Italy, United States and Germany. Chiara Cavalloni's co-authors include Mario Cazzola, Emanuela Boveri, Elisa Rumi, Emanuela Sant’Antonio, Daniela Pietra, Ilaria Carola Casetti, Virginia Valeria Ferretti, Elisa Roncoroni, Chiara Milanesi and Tiziano Barbui and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Chiara Cavalloni

14 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiara Cavalloni Italy	8	466	314	302	144	62	15	524
Ronan Chaligné France	8	324 0.7×	223 0.7×	296 1.0×	106 0.7×	14 0.2×	12	439
Paola Bertazzoni Italy	7	409 0.9×	242 0.8×	311 1.0×	141 1.0×	92 1.5×	12	509
Daniel Van Dyke United States	7	749 1.6×	409 1.3×	572 1.9×	238 1.7×	100 1.6×	17	848
Jiřı́ Schwarz Czechia	11	249 0.5×	220 0.7×	245 0.8×	64 0.4×	42 0.7×	36	403
Christine Zoi Greece	6	336 0.7×	226 0.7×	275 0.9×	127 0.9×	13 0.2×	10	429
Mayuka Nakatake Japan	9	226 0.5×	246 0.8×	238 0.8×	71 0.5×	14 0.2×	14	431
Samuel B. Luty United States	9	313 0.7×	193 0.6×	311 1.0×	133 0.9×	15 0.2×	13	500
L. Escribano Spain	7	205 0.4×	128 0.4×	184 0.6×	112 0.8×	139 2.2×	11	537
M. C. Martyré France	10	489 1.0×	245 0.8×	507 1.7×	169 1.2×	26 0.4×	14	648
Ilyas Chachoua Belgium	9	619 1.3×	471 1.5×	512 1.7×	171 1.2×	10 0.2×	14	765

Countries citing papers authored by Chiara Cavalloni

Since Specialization

Citations

This map shows the geographic impact of Chiara Cavalloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Cavalloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Cavalloni more than expected).

Fields of papers citing papers by Chiara Cavalloni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Cavalloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Cavalloni. The network helps show where Chiara Cavalloni may publish in the future.

Co-authorship network of co-authors of Chiara Cavalloni

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Cavalloni. A scholar is included among the top collaborators of Chiara Cavalloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Cavalloni. Chiara Cavalloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Michelerio, Andrea, Carlo Francesco Tomasini, Giacomo Fiandrino, et al.. (2023). Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin’s B lymphoma: a single center prospective clinico-pathological study. Frontiers in Medicine. 10. 1231003–1231003. 2 indexed citations

Abeykoon, Jithma P., Jorge J. Castillo, Joshua Gustine, et al.. (2021). Prognostic impact of depth of response in Waldenström macroglobulinemia patients treated with fixed duration chemoimmunotherapy.. Journal of Clinical Oncology. 39(15_suppl). 8049–8049. 1 indexed citations

Cavalloni, Chiara, Marzia Varettoni, Sara Rattotti, & Luca Arcaini. (2021). Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma. Expert Opinion on Pharmacotherapy. 22(13). 1643–1649. 1 indexed citations

Guglielmelli, Paola, Alessandra Carobbio, Elisa Rumi, et al.. (2020). Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. Blood Cancer Journal. 10(2). 21–21. 40 indexed citations

Carobbio, Alessandra, Paola Guglielmelli, Elisa Rumi, et al.. (2020). A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis. Blood Cancer Journal. 10(10). 100–100. 15 indexed citations

Rumi, Elisa, Emanuela Sant’Antonio, Chiara Cavalloni, et al.. (2020). Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib. Hematological Oncology. 38(4). 554–559. 4 indexed citations

Rumi, Elisa, Chiara Cavalloni, Giuditta Comolli, et al.. (2019). Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib. Blood. 134(Supplement_1). 1660–1660.

Rumi, Elisa, Emanuela Sant’Antonio, Emanuela Boveri, et al.. (2018). Diagnosis and management of prefibrotic myelofibrosis. Expert Review of Hematology. 11(7). 537–545. 12 indexed citations

Cavalloni, Chiara, Elisa Rumi, Virginia Valeria Ferretti, et al.. (2017). Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms. Oncotarget. 8(20). 33416–33421. 6 indexed citations

10.

Rumi, Elisa, Emanuela Boveri, Marta Bellini, et al.. (2017). Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. Oncotarget. 8(60). 101735–101744. 38 indexed citations

11.

Pietra, Daniela, Elisa Rumi, Virginia Valeria Ferretti, et al.. (2015). Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms. Leukemia. 30(2). 431–438. 178 indexed citations

12.

Finazzi, Guido, Alessandra Carobbio, Paola Guglielmelli, et al.. (2014). Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia. Blood. 124(16). 2611–2612. 64 indexed citations

13.

Rumi, Elisa, Ashot S. Harutyunyan, Daniela Pietra, et al.. (2014). CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis. Blood. 123(15). 2416–2419. 50 indexed citations

14.

Arcaini, Luca, Silvia Zibellini, Emanuela Boveri, et al.. (2011). The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 119(1). 188–191. 110 indexed citations

15.

Arcaini, Luca, Silvia Zibellini, Emanuela Boveri, et al.. (2011). The BRAF V600E Mutation in Hairy Cell Leukemia and Other Mature B-Cell Neoplasms. Blood. 118(21). 262–262. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact